Humana (NYSE:HUM) Price Target Lowered to $200.00 at Truist Financial

Humana (NYSE:HUM) had its price objective lowered by stock analysts at Truist Financial from $285.00 to $200.00 in a research report issued on Tuesday,MarketScreener reports. The firm currently has a “hold” rating on the insurance provider’s stock. Truist Financial’s price target would suggest a potential upside of 8.32% from the stock’s current price.

Several other research analysts have also recently issued reports on the stock. Weiss Ratings reiterated a “sell (d+)” rating on shares of Humana in a report on Thursday, January 22nd. The Goldman Sachs Group reduced their price objective on Humana from $215.00 to $158.00 and set a “sell” rating for the company in a research note on Friday. Leerink Partners cut their price target on shares of Humana from $267.00 to $185.00 and set a “market perform” rating on the stock in a report on Thursday, February 12th. Robert W. Baird reduced their price objective on Humana from $280.00 to $264.00 and set a “neutral” rating for the company in a research note on Thursday, December 11th. Finally, Raymond James Financial lowered their price target on shares of Humana from $340.00 to $230.00 and set an “outperform” rating on the stock in a report on Friday. Seven analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and five have given a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $232.13.

Humana Trading Up 0.3%

Shares of HUM opened at $184.64 on Tuesday. Humana has a one year low of $169.61 and a one year high of $315.35. The stock has a 50-day moving average price of $243.20 and a 200 day moving average price of $260.56. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.02 and a current ratio of 2.00. The company has a market capitalization of $22.21 billion, a P/E ratio of 18.88, a P/E/G ratio of 1.96 and a beta of 0.44.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, beating the consensus estimate of ($4.01) by $0.05. Humana had a net margin of 0.92% and a return on equity of 11.43%. The firm had revenue of $32.64 billion for the quarter, compared to analysts’ expectations of $32.08 billion. During the same period in the prior year, the company posted ($2.16) earnings per share. The firm’s quarterly revenue was up 11.3% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. Sell-side analysts forecast that Humana will post 16.47 EPS for the current fiscal year.

Hedge Funds Weigh In On Humana

Several institutional investors have recently modified their holdings of the stock. Illinois Municipal Retirement Fund grew its position in Humana by 9.6% in the third quarter. Illinois Municipal Retirement Fund now owns 49,658 shares of the insurance provider’s stock valued at $12,920,000 after acquiring an additional 4,351 shares during the last quarter. Bank of New York Mellon Corp raised its stake in shares of Humana by 161.5% during the third quarter. Bank of New York Mellon Corp now owns 1,717,767 shares of the insurance provider’s stock valued at $446,911,000 after acquiring an additional 1,060,767 shares during the last quarter. National Pension Service increased its stake in shares of Humana by 2.8% in the third quarter. National Pension Service now owns 189,601 shares of the insurance provider’s stock valued at $49,328,000 after buying an additional 5,150 shares during the period. Tejara Capital Ltd acquired a new stake in Humana during the 3rd quarter valued at approximately $1,873,000. Finally, Mediolanum International Funds Ltd bought a new position in Humana during the third quarter worth $27,606,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.